Molecular Imaging in Diagnosis of Tumor-induced Osteomalacia

Ming Yang, Krupa B. Doshi, Michael C. Roarke, Ba D. Nguyen

Research output: Contribution to journalReview article

Abstract

Tumor induced osteomalacia (TIO) is a rare paraneoplastic syndrome caused by overproduction of fibroblast growth factor 23 (FGF23) secreted by benign mesenchymal neoplasm. Due to its nonspecific clinical presentation or lack of awareness, the diagnosis of TIO is often significantly delayed resulting in patients' prolonged physical suffering or psychological distress. Successful detection or complete surgical resection of the causative tumor typically leads to rapid resolution of symptoms or reversal of biochemical imbalance. Nuclear medicine and molecular imaging have been playing a promising role as the first-line imaging modalities in the diagnosis and localization of occult FGF23 secreting mesenchymal tumor, especially with the emerging whole-body, head-to-toe Ga68-DOTATATE PET/CT technique. Combined focused diagnostic CT and/or MRI are imperative for accurate delineation of tumor and surgical guidance.

Original languageEnglish (US)
Pages (from-to)379-386
Number of pages8
JournalCurrent Problems in Diagnostic Radiology
Volume48
Issue number4
DOIs
StatePublished - Jul 1 2019

Fingerprint

Molecular Imaging
Neoplasms
Paraneoplastic Syndromes
Nuclear Medicine
Toes
Head
Psychology
Pain
Oncogenic osteomalacia
fibroblast growth factor 23

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Molecular Imaging in Diagnosis of Tumor-induced Osteomalacia. / Yang, Ming; Doshi, Krupa B.; Roarke, Michael C.; Nguyen, Ba D.

In: Current Problems in Diagnostic Radiology, Vol. 48, No. 4, 01.07.2019, p. 379-386.

Research output: Contribution to journalReview article

Yang, Ming ; Doshi, Krupa B. ; Roarke, Michael C. ; Nguyen, Ba D. / Molecular Imaging in Diagnosis of Tumor-induced Osteomalacia. In: Current Problems in Diagnostic Radiology. 2019 ; Vol. 48, No. 4. pp. 379-386.
@article{61b77d3c48b740388d9f8432a22018c1,
title = "Molecular Imaging in Diagnosis of Tumor-induced Osteomalacia",
abstract = "Tumor induced osteomalacia (TIO) is a rare paraneoplastic syndrome caused by overproduction of fibroblast growth factor 23 (FGF23) secreted by benign mesenchymal neoplasm. Due to its nonspecific clinical presentation or lack of awareness, the diagnosis of TIO is often significantly delayed resulting in patients' prolonged physical suffering or psychological distress. Successful detection or complete surgical resection of the causative tumor typically leads to rapid resolution of symptoms or reversal of biochemical imbalance. Nuclear medicine and molecular imaging have been playing a promising role as the first-line imaging modalities in the diagnosis and localization of occult FGF23 secreting mesenchymal tumor, especially with the emerging whole-body, head-to-toe Ga68-DOTATATE PET/CT technique. Combined focused diagnostic CT and/or MRI are imperative for accurate delineation of tumor and surgical guidance.",
author = "Ming Yang and Doshi, {Krupa B.} and Roarke, {Michael C.} and Nguyen, {Ba D.}",
year = "2019",
month = "7",
day = "1",
doi = "10.1067/j.cpradiol.2018.06.005",
language = "English (US)",
volume = "48",
pages = "379--386",
journal = "Current Problems in Diagnostic Radiology",
issn = "0363-0188",
publisher = "Mosby Inc.",
number = "4",

}

TY - JOUR

T1 - Molecular Imaging in Diagnosis of Tumor-induced Osteomalacia

AU - Yang, Ming

AU - Doshi, Krupa B.

AU - Roarke, Michael C.

AU - Nguyen, Ba D.

PY - 2019/7/1

Y1 - 2019/7/1

N2 - Tumor induced osteomalacia (TIO) is a rare paraneoplastic syndrome caused by overproduction of fibroblast growth factor 23 (FGF23) secreted by benign mesenchymal neoplasm. Due to its nonspecific clinical presentation or lack of awareness, the diagnosis of TIO is often significantly delayed resulting in patients' prolonged physical suffering or psychological distress. Successful detection or complete surgical resection of the causative tumor typically leads to rapid resolution of symptoms or reversal of biochemical imbalance. Nuclear medicine and molecular imaging have been playing a promising role as the first-line imaging modalities in the diagnosis and localization of occult FGF23 secreting mesenchymal tumor, especially with the emerging whole-body, head-to-toe Ga68-DOTATATE PET/CT technique. Combined focused diagnostic CT and/or MRI are imperative for accurate delineation of tumor and surgical guidance.

AB - Tumor induced osteomalacia (TIO) is a rare paraneoplastic syndrome caused by overproduction of fibroblast growth factor 23 (FGF23) secreted by benign mesenchymal neoplasm. Due to its nonspecific clinical presentation or lack of awareness, the diagnosis of TIO is often significantly delayed resulting in patients' prolonged physical suffering or psychological distress. Successful detection or complete surgical resection of the causative tumor typically leads to rapid resolution of symptoms or reversal of biochemical imbalance. Nuclear medicine and molecular imaging have been playing a promising role as the first-line imaging modalities in the diagnosis and localization of occult FGF23 secreting mesenchymal tumor, especially with the emerging whole-body, head-to-toe Ga68-DOTATATE PET/CT technique. Combined focused diagnostic CT and/or MRI are imperative for accurate delineation of tumor and surgical guidance.

UR - http://www.scopus.com/inward/record.url?scp=85050886345&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050886345&partnerID=8YFLogxK

U2 - 10.1067/j.cpradiol.2018.06.005

DO - 10.1067/j.cpradiol.2018.06.005

M3 - Review article

C2 - 30078476

AN - SCOPUS:85050886345

VL - 48

SP - 379

EP - 386

JO - Current Problems in Diagnostic Radiology

JF - Current Problems in Diagnostic Radiology

SN - 0363-0188

IS - 4

ER -